Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by TexRitteron Dec 18, 2017 11:31am
156 Views
Post# 27178730

RE:7 or lower before NewYear?

RE:7 or lower before NewYear?I don't think anyone studying the situation would be impressed with CMed's resistance; I doubt their independent (non execs) shareholders are.. Their moves/comments are detrimental in some cases to their own company. The Michigan announcement was absurd. The Newstrike deal is not a good deal...except for Newstrike shareholders. The continued mentioning of the Tragically Hip goes against the guidelines with respect to celebrity endorsements. The statement that ACB shares are paper money and overvalued are damaging to an entire sector whose valuation is speculative and a closer inspection would have any objective person comparing Aurora to CMed as seeing CMed as even more "overvalued." I do not go to the CmEd board; not into foolsih board games. But there is no way that anyone is impressed with Zettl. Think about it - one or more other CMed execs want this deal to happen and were unhappy with their company performance; the 3 top shareholders - including 2 Saskatchewan based financial management companies - were not happy with Cmed management and execution and wanted this merger. None of the smart money is happy with their results. Don't cponfuse market activity with "successful resistance" - people are looking to profit from tihs, including the gamble to buy CMed stock in hopes of cashing in on the deal offered by Aurora in the event of a successful takeover.
Bullboard Posts